Previous studies in murine MG showed the activation of NLRP3 and increased IL-1β production following treatment with oligomeric Aβ via Toll-like receptors (TLRs), which was exacerbated by iron (Burm et al., 2015; Nnah et al., 2020). The gene discussed is NLRP3; the disease is myasthenia gravis.